TGFB3 and cancer: More peripheral positioning was detected in one high Gleason score specimen for both SP100 and TGFB3, resulting in a false positive rate of 6.3% (1/16) and 8.3% (1/12), respectively, for intermediate and high Gleason score cancers (Table 1).